Reuters logo
Albany Molecular says Bristol-Myers stops development of depression drug
August 12, 2013 / 5:45 PM / 4 years ago

Albany Molecular says Bristol-Myers stops development of depression drug

(Reuters) - Albany Molecular Research Inc said partner Bristol-Myers Squibb Co would stop developing their experimental depression therapy.

Albany’s shares tumbled 19 percent to $10.24 in afternoon trading.

Albany said Bristol-Myers stopped two mid-stage studies of the drug after it failed to show superiority over two other antidepressants. (link.reuters.com/fax32v)

Albany said the decision would not have an impact on its forecasts for the third quarter and 2013.

Reporting by Pallavi Ail in Bangalore; Editing by Saumyadeb Chakrabarty

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below